Int'l : +1(646) 600-5072 | query@kbvresearch.com
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Asia-Pacific Biophotonics Market, published by KBV Research, the Asia-Pacific Biophotonics Market is expected to register a CAGR of 12.7% during the forecast period.
The In-Vivo market dominated the Asia Pacific Biophotonics Market in 2015, growing at a CAGR of 11.9% during the forecast period. The In-Vitro market is expected to attain a market size of $5,893.9 million by 2022.
The See-Through Imaging market dominated the Asia Pacific Biophotonics Market in 2015, growing at a CAGR of 11.7% during the forecast period. The Microscopy market is expected to attain a market size of $3,260.8 million by 2022. However, Inside Imaging market is expected to grow at CAGR of 13.1% during 2016-2022.
The China market dominated the Asia Pacific Biophotonics Market in 2015, growing at a CAGR of 9.1% during the forecast period. The India market is expected to attain a market size of $2,878.1 million by 2022. However, Japan market is expected to grow at CAGR of 13.3% during 2016-2022.
The report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the countries in the region. The key influencing factors of the Asia-Pacific Biophotonics have been discussed in the report along with the elaborated company profiles of Oxford Instruments, Thermo Fisher Scientific, Lumenis Ltd, Carl Zeiss AG, Olympus Corporation, Hamamatsu Photonics K.K., Becton, Dickinson and Company, Perkinelmer, Inc., and Zecotek Photonics, Inc.
Full report :- https://www.kbvresearch.com/asia-pacific-biophotonics-market/
Related Reports-